Annual report pursuant to Section 13 and 15(d)

PREPAID EXPENSES AND OTHER CURRENT ASSETS

v3.24.1
PREPAID EXPENSES AND OTHER CURRENT ASSETS
 12 Months Ended
Dec. 31, 2023
Prepaid Expenses And Other Current Assets  
PREPAID EXPENSES AND OTHER CURRENT ASSETS

NOTE 7. PREPAID EXPENSES AND OTHER CURRENT ASSETS

 

The Company’s prepaid expenses and other current assets consist of the following:

 

    December 31, 2023     December 31, 2022  
Other receivables   £ 51,584     £ 56,264  
VAT owed to the Company     135,642       27,055  
Prepaid clinical trial costs     307,519       307,519  
Deferred clinical trial testing costs     1,177,500       -  
Other prepayments     522,480       528,618  
Total   £ 2,194,725     £ 919,456  

 

 

The fair value of trade and other receivables are not materially different to the book value.